Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
€36.02 - €62.05
Next Earnings Date
May 13 2025
Next Earnings Date
May 13 2025
Latest price
Market Cap | €1.17B |
EV | €1.11B |
Shares Outstanding | 20.85M |
Beta | 1.50 |
Analyst Rating | BUY |
Analyst Target Price | €66.00 |
P/E 2025E | 22.95x |
P/Revenue 2025E | 3.56x |
Revenue | 17.90% |
EPS | 4.90% |
Operating Cash Flow | 25.30% |
Free Cash Flow | 114.60% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 49.70% |
Net Profit Margin 2025E | 15.47% |
ROE 2025E | 18.90% |
ROCE 2024 | 17.97% |
DPS 2025E | €0.50 |
Payout Ratio 2025E | 20.92% |
Div. Yield 2025E | 0.93% |
DPS Last 3Y CAGR | -53.60% |
Price
%
1M
3M
6M
1Y
3Y
5Y
Eckert & Ziegler SE
EUZ
Sector
Healthcare
Industry
Medical - Devices
CEO
Hasselmann, Harald
Employees
1,085
Website
www.ezag.comIPO Date
1999-05-26
Headquarters
Robert-ROessle-Str. 10, Berlin, Berlin, 13125, Germany
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved